Vaginal Pessary Market Analysis

The global vaginal pessary market was valued at US$ 324.87 million in 2022, and it is expected to grow at a compound annual growth rate (CAGR) of 10.00% during the forecast period from 2022 to 2030. By 2030, the market is projected to reach a value of US$ 696.40 million. This growth is primarily driven by factors such as the increasing prevalence of pelvic organ prolapse and stress urinary incontinence, as well as the rising number of elderly individuals who are prone to pelvic organ prolapse.

The demand for noninvasive treatment options for these conditions is also on the rise globally, which is expected to further contribute to the growth of the overall vaginal pessary market during the forecast period from 2022 to 2030. These factors, combined with the growing awareness and availability of vaginal pessaries as a viable treatment option, are expected to propel market expansion in the coming years.

Vaginal Pessary Market Regional Insights

• North America: In 2022, North America held a significant share in the vaginal pessary market. The region's market growth can be attributed to factors such as the presence of advanced healthcare infrastructure, high awareness about pelvic organ prolapse and stress urinary incontinence, and the availability of technologically advanced medical devices. Additionally, a large geriatric population and increasing demand for noninvasive treatment options contribute to market growth in this region.
• Europe: Europe is another prominent market for vaginal pessaries. The region's market growth is driven by factors such as a high prevalence of pelvic organ prolapse and stress urinary incontinence among women, increasing healthcare expenditure, and favorable reimbursement policies. Additionally, the presence of key market players and ongoing research and development activities further contribute to the market's expansion in Europe.
• Asia Pacific: The vaginal pessary market in Asia Pacific is expected to witness significant growth during the forecast period. This growth can be attributed to factors such as a large population base, increasing awareness about pelvic floor disorders, and rising healthcare expenditure. Moreover, the growing adoption of advanced medical technologies and the expansion of healthcare infrastructure in countries like China and India are likely to fuel market growth in this region.

Vaginal Pessary Market Drivers:

1. Increasing Prevalence of Pelvic Organ Prolapse and Stress Urinary Incontinence: The growing prevalence of pelvic organ prolapse and stress urinary incontinence among women is a significant driver for the vaginal pessary market. These conditions affect a large number of women worldwide, creating a demand for effective treatment options such as vaginal pessaries.
2. Rising Geriatric Population: The global increase in the geriatric population, who are more prone to pelvic organ prolapse, contributes to the growth of the vaginal pessary market. As the elderly population continues to grow, the demand for treatment options to manage pelvic floor disorders is expected to rise, driving market growth.
3. Noninvasive Treatment Preference: There is a growing preference for noninvasive treatment options among patients. Vaginal pessaries provide a noninvasive approach to manage pelvic organ prolapse and stress urinary incontinence, avoiding the need for surgery. The demand for noninvasive treatments is increasing, which positively impacts the market growth of vaginal pessaries.
4. Awareness and Education: Increasing awareness about pelvic floor disorders and the availability of treatment options such as vaginal pessaries are driving market growth. Educational campaigns, initiatives by healthcare organizations, and awareness programs contribute to improving understanding and recognition of these conditions, leading to increased demand for treatment options.

Vaginal Pessary Market Opportunities:

1. Emerging Markets: There is significant potential for market growth in emerging economies. Rapidly developing healthcare infrastructure, increasing disposable income, and improving healthcare awareness in countries across Asia, Latin America, and Africa present untapped opportunities for market expansion. These regions offer a large patient pool and potential market demand for vaginal pessaries.
2. Technological Advancements: Continued research and development in the field of vaginal pessaries present opportunities for technological advancements. Innovations in design, materials, and manufacturing processes can lead to the development of more comfortable, effective, and patient-friendly pessaries. Advancements such as adjustable pessaries or those integrated with sensors for real-time monitoring could open up new possibilities and market segments.
3. Focus on Patient Education and Awareness: Opportunities exist to enhance patient education and awareness programs about pelvic floor disorders, available treatment options, and the benefits of vaginal pessaries. Providing comprehensive information to patients and healthcare professionals can lead to increased acceptance and adoption of pessaries as a treatment choice. Awareness campaigns targeted at both patients and healthcare providers can help drive market growth.
4. Integration of Digital Health Solutions: The integration of digital health solutions such as remote monitoring, telemedicine, and data analytics presents opportunities for the vaginal pessary market. Remote monitoring can provide healthcare professionals with valuable insights into patient compliance and treatment effectiveness. Telemedicine consultations can increase accessibility to specialized care. Leveraging digital health technologies can improve patient outcomes and drive market growth.

Vaginal Pessary Market Trends:

1. Shift towards Non-Surgical Treatment Options: There is a noticeable trend towards non-surgical treatment options for pelvic organ prolapse and stress urinary incontinence. Vaginal pessaries, as a non-surgical intervention, are gaining popularity among patients and healthcare providers due to their effectiveness, safety, and non-invasiveness. This trend is driven by the desire to avoid surgical risks, reduce recovery time, and preserve natural anatomical structures.
2. Growing Focus on Patient Comfort and Quality of Life: Patient comfort and quality of life have become key considerations in the development and selection of vaginal pessaries. Manufacturers are prioritizing designs that offer improved comfort, reduced discomfort during wear, and minimal interference with daily activities. Patient feedback and preferences are being incorporated into product development to enhance overall patient satisfaction.
3. Increasing Adoption of Digital Health Solutions: The integration of digital health solutions is on the rise in the vaginal pessary market. This includes the use of mobile applications, wearable devices, and remote monitoring systems for tracking pessary usage, monitoring symptoms, and providing personalized care. Digital health solutions enable healthcare professionals to remotely monitor patient progress, offer virtual consultations, and enhance patient engagement.
4. Rising Demand for Personalized Treatment: There is an increasing demand for personalized treatment approaches in the vaginal pessary market. Patients and healthcare providers are recognizing the importance of tailoring pessaries to individual patient needs and anatomical requirements. Customizable pessaries that offer a range of sizes, shapes, and support levels are being developed to address this demand.

 Vaginal Pessary Market Size Report Coverage

Report Coverage	Details
Base Year:	2022	Market Size in 2022:	US$ 324.87 Mn
Historical Data for:	2017 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	10.00%	2030 Value Projection:	US$ 696.40 Mn
Geographies covered:	North America: U.S. and Canada Latin America: Brazil, Argentina, Mexico, and Rest of Latin America Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific Middle East: GCC Countries, Israel, and Rest of Middle East Africa: South Africa, North Africa, and Central Africa
Segments covered:	By Product Type: Ring Pessaries, Gellhorn Pessaries, Donut Pessaries, Cube Pessaries, Other Types By Material: Silicone Pessaries, Rubber Pessaries, Plastic Pessaries, Other Materials By Size: Small-sized Pessaries, Medium-sized Pessaries, Large-sized Pessaries By Application: Pelvic Organ Prolapse, Stress Urinary Incontinence By End User: Hospitals, Specialty Clinics, Gynecology Centers, Others By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others
Companies covered:	CooperSurgical, Inc., MedGyn Products, Inc., Thomas Medical, Inc., Smiths Medical, Milex Products, Inc., Personal Medical Corp., Panpac Medical Corp., Gyneas, Uromed Kurt Drews KG, Integra LifeSciences Corporation, Boston Scientific Corporation, Cook Medical, Medtronic plc, C. R. Bard, Inc. (BD), Coloplast A/S
Growth Drivers:	Increasing Prevalence of Pelvic Organ Prolapse and Stress Urinary Incontinence Rising Geriatric Population Noninvasive Treatment Preference Awareness and Education
Restraints & Challenges:	Lack of Standardization Patient Compliance and Discomfort Limited Awareness and Stigma

Vaginal Pessary Market Restraints:

1. Limited Awareness and Stigma: Despite efforts to increase awareness, there is still a lack of general knowledge and understanding about pelvic floor disorders and treatment options like vaginal pessaries. Stigma associated with discussing and seeking treatment for these conditions can hinder patient acceptance and uptake of pessaries, leading to lower market penetration.
2. Lack of Standardization: The lack of standardized guidelines and protocols for selecting, fitting, and managing vaginal pessaries can pose challenges. Variation in healthcare provider practices and limited consensus on best practices may impact treatment outcomes and patient satisfaction. Establishing standardized protocols and guidelines can help ensure consistent and optimal care.
3. Patient Compliance and Discomfort: Achieving and maintaining patient compliance with pessary use can be challenging. Some patients may experience discomfort, irritation, or difficulty with insertion or removal, which can affect adherence to treatment. Addressing patient concerns, providing proper education and support, and offering a range of pessary options can help overcome these challenges.

Recent Developments

New product launches

1. Gynemesh™ PS Prolapse System by Ethicon (2021): Ethicon, a subsidiary of Johnson & Johnson, launched the Gynemesh™ PS Prolapse System in 2021. It is designed to provide support for pelvic organ prolapse and offers a minimally invasive treatment option.
2. Gellhorn Pessary by CooperSurgical (2020): CooperSurgical introduced the Gellhorn Pessary in 2020. This pessary is made from a soft and flexible material, aiming to provide comfort and support for women with pelvic organ prolapse or stress urinary incontinence.
3. IncoShape Pessary by Gynial (2020): Gynial, a German medical device company, launched the IncoShape Pessary in 2020. It is designed to manage stress urinary incontinence and offers an adjustable and reusable solution for women.

Acquisition and partnerships

1. CooperSurgical Acquires The AEGEA Medical (2020): In 2020, CooperSurgical, a leading women's health company, announced the acquisition of The AEGEA Medical, a medical technology company focused on developing minimally invasive solutions for women's health. This acquisition expanded CooperSurgical's portfolio of women's health products, including those related to pelvic organ prolapse and stress urinary incontinence.
2. Boston Scientific Partners with Pelvital (2020): Boston Scientific, a global medical technology company, partnered with Pelvital, a company specializing in pelvic health solutions. This partnership aimed to commercialize and distribute the non-invasive FemPulse™ System developed by Pelvital. The FemPulse™ System is designed to treat stress urinary incontinence in women.
3. Cogentix Medical Acquired by Laborie Medical Technologies (2018): In 2018, Laborie Medical Technologies, a leading diagnostic and therapeutic medical technology company, acquired Cogentix Medical, a company focused on urology and gynecology. This acquisition broadened Laborie's product portfolio in the field of pelvic health, including vaginal pessaries and other devices used for the management of pelvic floor disorders.

Top companies in Vaginal Pessary Market

1. CooperSurgical, Inc.
2. MedGyn Products, Inc.
3. Thomas Medical, Inc.
4. Smiths Medical
5. Milex Products, Inc.
6. Personal Medical Corp.
7. Panpac Medical Corp.
8. Gyneas
9. Uromed Kurt Drews KG
10. Integra LifeSciences Corporation
11. Boston Scientific Corporation
12. Cook Medical
13. Medtronic plc
14. C. R. Bard, Inc. (BD)
15. Coloplast A/S